03:49 AM EDT, 08/14/2026 (MT Newswires) -- Colin Walsh, Director, on August 05, 2026, executed a purchase for 585,000 shares in Attovia Therapeutics ( ATTO ) for $10,285,000. Following the Form 4 filing with the SEC, Walsh has control over a total of 3,020,632 common shares of the company, with 3,020,632 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2058707/000186617426000009/xslF345X05/wk-form4_1786672367.xml